Business Context and Reporting Period
Soren Acquisition Corp., a Cayman Islands emerging growth company, filed this Form 8-K on January 8, 2026, to report the consummation of its initial public offering (IPO). The company is incorporated in the Cayman Islands with principal executive offices in Miami, Florida.
Key Financial Metrics
- Gross Proceeds from IPO: $253,000,000 from the sale of 25,300,000 Units at $10.00 per Unit.
- Gross Proceeds from Private Placement: $5,000,000 from the sale of 5,000,000 Private Placement Warrants to Soren Holdings LLC at $1.00 per warrant.
- Total Funds in Trust: $253,000,000 placed in a U.S.-based trust account maintained by Continental Stock Transfer & Trust Company.
- Securities Issued: Class A ordinary shares (SORN), Units (SORNU), and Warrants (SORNW) registered on The Nasdaq Stock Market LLC.
- Warrant Exercise Price: $11.50 per share.
Material Changes
This filing represents the company's initial public offering and the transition from a private entity to a publicly traded company. The filing does not provide comparative financial data against a prior period as this is the IPO event. The filing notes that the trust account balance includes up to $10,120,000 of business combination marketing fees payable to BTIG, LLC.
Outlook, Risks, and Unusual Items
The company has completed its IPO and private placement, with proceeds secured in a trust account pending a future business combination. An audited balance sheet as of January 8, 2026, is included as Exhibit 99.1. The filing does not contain specific forward-looking guidance, risk factors, or management commentary beyond the description of the transaction mechanics and the inclusion of the audited balance sheet.
Investor Verification Checklist
- Verify the audited balance sheet (Exhibit 99.1) to confirm the exact cash balance and liabilities after deducting offering costs and marketing fees.
- Confirm the specific terms of the business combination marketing fees payable to BTIG, LLC, including the conditions for payment.
- Review the warrant terms, specifically the redemption provisions and the $11.50 exercise price.
- Check the status of the over-allotment option exercise (3,300,000 Units) and its impact on the total share count.